Position in CHRS
as of Jun 30, 2026
· filed Jul 1, 2026
Position Value
$186,529
-$38,849 QoQ
Shares Held
133,235
-0.1% QoQ
Ownership
0.086%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#40
of 145 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 2%
Shared 0%
None 98%
Common Shares in CHRS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PVG ASSET MANAGEMENT CORP holds $3,151,080 across 9 Biotechnology names. CHRS ranks #6 (5.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AVXL |
Anavex Life Sciences Corp.
|
327,344 | $847,820 | |
| 2 | VKTX |
Viking Therapeutics, Inc.
|
19,818 | $773,100 | |
| 3 | IMRX |
Immuneering Corp
|
146,451 | $730,790 | |
| 4 | MDWD |
MediWound Ltd.
|
18,122 | $266,393 | |
| 5 | ALT |
Altimmune, Inc.
|
66,120 | $201,004 | |
| 6 | CHRS |
Coherus Oncology, Inc.
This page
|
133,235 | $186,529 | |
| 7 | ARDX |
Ardelyx, Inc.
|
11,393 | $58,104 | |
| 8 | MAIA |
MAIA Biotechnology, Inc.
|
34,135 | $49,154 |
All Filings in CHRS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $186,529 | 133,235 | Shares | Sole | 2026-07-01 | |
| 2026-03-31 | $225,378 | 133,360 | Shares | Sole | 2026-06-16 | |
| No filing history on record for this holder in this stock. | ||||||